BSE - Delayed Quote INR

Procter & Gamble Hygiene and Health Care Limited (PGHH.BO)

Compare
15,964.00 -242.90 (-1.50%)
At close: 3:28 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
41,915,700.00
41,915,700.00
39,052,100.00
37,924,500.00
35,702,400.00
--
Cost of Revenue
16,141,900.00
16,141,900.00
16,630,300.00
17,621,100.00
13,285,900.00
--
Gross Profit
25,773,800.00
25,773,800.00
22,421,800.00
20,303,400.00
22,416,500.00
--
Operating Expense
16,506,200.00
16,506,200.00
14,319,100.00
12,359,000.00
13,837,600.00
--
Operating Income
9,267,600.00
9,267,600.00
8,102,700.00
7,944,400.00
8,578,900.00
--
Net Non Operating Interest Income Expense
-267,800.00
-267,800.00
-113,800.00
131,000.00
261,800.00
--
Pretax Income
9,392,000.00
9,392,000.00
8,394,700.00
7,901,400.00
8,698,900.00
--
Tax Provision
2,641,800.00
2,641,800.00
1,613,300.00
2,143,900.00
2,181,000.00
--
Net Income Common Stockholders
6,750,200.00
6,750,200.00
6,781,400.00
5,757,500.00
6,517,900.00
--
Diluted NI Available to Com Stockholders
6,750,200.00
6,750,200.00
6,781,400.00
5,757,500.00
6,517,900.00
--
Basic EPS
229.57
207.95
208.91
177.37
200.79
--
Diluted EPS
229.57
207.95
208.91
177.37
200.79
--
Basic Average Shares
32,460.59
32,460.69
32,460.87
32,460.74
32,460.74
--
Diluted Average Shares
32,460.59
32,460.69
32,460.87
32,460.74
32,460.74
--
Rent Expense Supplemental
--
--
29,600.00
43,400.00
44,900.00
36,600.00
Total Expenses
32,648,100.00
32,648,100.00
30,949,400.00
29,980,100.00
27,123,500.00
--
Net Income from Continuing & Discontinued Operation
6,750,200.00
6,750,200.00
6,781,400.00
5,757,500.00
6,517,900.00
--
Normalized Income
6,843,848.96
6,843,848.96
6,781,400.00
5,833,427.24
6,669,104.43
--
Interest Income
--
--
362,100.00
242,900.00
322,900.00
338,500.00
Interest Expense
267,800.00
267,800.00
113,800.00
111,900.00
61,100.00
--
Net Interest Income
-267,800.00
-267,800.00
-113,800.00
131,000.00
261,800.00
--
EBIT
9,659,800.00
9,659,800.00
8,508,500.00
8,013,300.00
8,760,000.00
--
EBITDA
10,224,800.00
10,224,800.00
9,092,100.00
8,542,100.00
9,236,600.00
--
Reconciled Cost of Revenue
16,141,900.00
16,141,900.00
16,630,300.00
17,621,100.00
13,285,900.00
--
Reconciled Depreciation
565,000.00
565,000.00
583,600.00
528,800.00
476,600.00
--
Net Income from Continuing Operation Net Minority Interest
6,750,200.00
6,750,200.00
6,781,400.00
5,757,500.00
6,517,900.00
--
Total Unusual Items Excluding Goodwill
-130,300.00
-130,300.00
--
-104,200.00
-201,800.00
--
Total Unusual Items
-130,300.00
-130,300.00
--
-104,200.00
-201,800.00
--
Normalized EBITDA
10,355,100.00
10,355,100.00
9,092,100.00
8,646,300.00
9,438,400.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-36,651.04
-36,651.04
--
-28,272.76
-50,595.57
--
6/30/2020 - 1/5/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers